Literature DB >> 971789

The problems of retinal blood flow in diabetes.

E M Kohner.   

Abstract

Three methods are available for measurement of retinal blood flow: cinefluroescein angiography, measurement of mean transit time, and estimation of volume flow by laser-Dopler velocimetry. Cineangiography requires intra-arterial injection for volume flow measurement, and this greatly inhibits its use. Difficulties also arise in estimating the relation of the axial to the mean flow, since it is now known that the retinal flow is plug flow. Transit time measurement using fluroescein has recently been automated and thus allows for more accurate measurement and better estimation of volume flow. The problems of estimating vascular volume and allowing for leakage have not been overcome. Laser-Doppler velocimetry measures mean red cell velocity but its relation to volume flow has not been established. Using the mean-transit-time method, several authors have found reduced transit time and increased volume flow in patients with mild and no retinopathy, compared to normals and those with more severe lesions, This most probably is due to autoregulatory adaptation and, possibly, to hypoxia. In more severe retinopathy, flow is reduced and there are large areas of nonperfusion. These areas are the result of abnormality of the endothelial cells and also of the blood within the vessels, which probably coagulates more easily than in normals. These areas are of importance because they stimulate the growth of new vessels.

Entities:  

Mesh:

Year:  1976        PMID: 971789

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

1.  Pathogenesis of diabetic microangiopathy.

Authors: 
Journal:  Br Med J       Date:  1977-06-18

2.  Effects of intensified insulin treatment on retinal vessels in diabetic patients.

Authors:  O Brinchmann-Hansen; K Dahl-Jørgensen; K F Hanssen; L Sandvik
Journal:  Br J Ophthalmol       Date:  1988-09       Impact factor: 4.638

3.  Identification of persistent defects in insulin receptor structure and function capillary endothelial cells from diabetic rats.

Authors:  C F Kwok; B J Goldstein; D Muller-Wieland; T S Lee; C R Kahn; G L King
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

4.  Video fluorescein angiography: method and clinical application.

Authors:  S Wolf; F Jung; H Kiesewetter; N Körber; M Reim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

5.  Retinal cotton-wool spots: an early finding in diabetic retinopathy?

Authors:  M S Roy; M E Rick; K E Higgins; J C McCulloch
Journal:  Br J Ophthalmol       Date:  1986-10       Impact factor: 4.638

6.  Quantification of characteristic blood-flow parameters in the vessels of the retina with a picture analysis system for video-fluorescence angiograms: initial findings.

Authors:  F Jung; H Kiesewetter; N Körber; S Wolf; M Reim; G Müller
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

7.  Measurement of flow-physiologic parameters of retinal blood circulation in type 1 and 2 diabetics before and after photocoagulation.

Authors:  B Oswald; W Vilser; H Oswald; A Jütte; D Schweitzer; E Königsdörffer; A Deufrains; U Dietze
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

8.  The effect of acute hyperglycaemia on the retinal circulation of the normal cat.

Authors:  A Atherton; D W Hill; H Keen; S Young; E J Edwards
Journal:  Diabetologia       Date:  1980-03       Impact factor: 10.122

9.  Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography.

Authors:  S Tesfaye; N Harris; J J Jakubowski; C Mody; R M Wilson; I G Rennie; J D Ward
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

10.  Measurement of retinal blood flow in diabetes by the blue-light entoptic phenomenon.

Authors:  T J Fallon; P Chowiencyzk; E M Kohner
Journal:  Br J Ophthalmol       Date:  1986-01       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.